AzTrials
AzTrials

Emergence AgitationNCT03846284

Caudal Versus Intravenous Magnesium Sulfate on Emergence Agitation After Sevoflurane In Children.

A study testing Bupivacaine, Magnesium sulfate 50mg and Magnesium sulfate 30 mg in people with Emergence Agitation and Postoperative Pain, run by Mansoura University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Sevoflurane is the agent of choice for induction and maintenance of day care anesthesia in children and has a wide acceptance among pediatric anesthesiologists. Emergence agitation (EA) is a frequent postoperative complication in pediatric patients receiving inhalational anesthetics with a rapid recovery, e.g. Read more about this study

Who is it for?
Ages 2 to 6 years
Conditions the study is for
Emergence Agitation, Postoperative Pain
What is being tested?
Bupivacaine, Magnesium sulfate 50mg and Magnesium sulfate 30 mg
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
93 participants
Where
1 siteEgypt
Study dates
8 Oct 2017to 1 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • -All participants undergoing lower abdominal surgeries

Who cannot join

  • All participants with:-
  • history of developmental delay,
  • mental retardation,
  • psychological disorders or
  • Epilepsy which can make observational pain intensity assessment difficult,
  • a known or suspect coagulopathy,
  • a known allergy to any of the study drugs and
  • any signs of infection at the site of the proposed caudal block.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Marwa ibrahim mohamed abdo

    Al Mansurah

Other trials in Egypt

About this study

Official title: Caudal Versus Intravenous Magnesium Sulfate In The Prevention OF Emergence Agitation After Sevoflurane Anesthesia For Lower Abdominal Surgeries In Children.

Sevoflurane is the agent of choice for induction and maintenance of day care anesthesia in children and has a wide acceptance among pediatric anesthesiologists.

Emergence agitation (EA) is a frequent postoperative complication in pediatric patients receiving inhalational anesthetics with a rapid recovery, e.g. sevoflurane Magnesium sulfate is a non anesthetic N-methyl-D-aspartate receptor antagonist, Regional anesthetic techniques have major two benefits which are lowering anesthetic requirements intraoperatively and providing adequate postoperative pain relief.

Read more

Magnesium sulfate is an adjuvant that alters the perception and duration of pain by serving as an antagonist of N-methyl-D-aspartate glutamate receptors. Caudal injection of bupivacaine with magnesium sulfate in pediatric patients after inguinoscrotal operations provided adequate postoperative analgesia without producing many side effects. Caudal block with local anesthetic with or without adjuvants may prevent emergence agitation with effective postoperative pain management.

  • So the aim of this study is to compare the efficacy of caudal versus intravenous magnesium sulfate infusions in controlling emergence agitations after inhalational sevoflurane anesthesia in children who will undergo lower abdominal surgeries.

Participants and methods

All participants will receive caudal block with bupivacaine 0.25% 1mg/kg dialed in 10 cm saline.

The participants will be divided to 3 groups

  1. Bupivacaine group (B group) (group 1) N = 31 :-
  2. Magnesium sulfate caudal group (MC group) (group 2) N = 31 :-
  3. Magnesium sulfate I.V group (MV group) (group 3) N = 31 :-

Postoperative assessment in the ( PACU):-

  • The oxygen saturation (SO2), heart rate (HR), and mean arterial pressure (MAP) are monitored by the observer blinded to group allocation on admission and 10 mins till discharge (0, 10, 20, 30, 40, 50, 60mints, time of discharge) from the PACU.
  • Emergence agitations (Pediatric anesthesia emergency delirium scale (PAED) The presence of Emergence agitation and its severity will be measured using (PAED).

The presence of Pain and its severity will be measured using FLACC scale.

  • Time of first postoperative administration of fentanyl in mints
  • Modified Aldrete score :- The discharge from the PACU will be measured using Modified Aldrete score.
Read the detailed description

Participants and methods All participants will receive caudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline.

The participants will be divided to 3 groups

  1. Bupivacaine group (B group) (group 1) N = 31 :- The participants will receive caudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline. + I.V injection of 10 cm saline over 10 mins then, followed by I.V infusion 50 cm saline with rate 10-20 ml/h according to child weight.
  2. Magnesium sulfate caudal group (MC group) (group 2) N = 31 :- The participants will receive caudal block with bupivacaine 0.25% 1mg/kg plus Magnesium sulfate 50 mg diluted in 10 cm saline.
  • I.V injection of 10 cm saline over 10 mins then, followed by I.V infusion of 50 cm saline with rate 10-20 ml/h according to child weight.
  1. Magnesium sulfate I.V group (MV group) (group 3) N = 31 :- The participants will receive caudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline. + I.V injection of Magnesium sulfate 30mg/kg diluted in 10 cm saline over 10 mins then, followed by I.V infusion one ampule of Magnesium sulfate 500mg diluted in 50 cm saline with rate 10 mg/kg/h. Standard monitoring is used during anesthesia and surgery include :- electrocardiography, non-invasive arterial pressure, arterial oxygen saturation using pulse oximeter and end-tidal concentrations are measured using capnography. An intravenous line is secured before induction of anesthesia, all participants will receive a standardized rapid sequence induction of anesthesia and oxygen administration for 3 minutes. Anesthesia is induced with Inhalation of 8% sevoflurane without use of muscle relaxant, cricoid pressure is applied and the trachea intubated with a suitable-size endotracheal tube. Maintained end-tidal sevoflurane concentration will be between 2.5-3.5 and will be titrated. The participants will breath spontaneously during surgery and tidal volume will be adjusted to maintain normocarbia. I.V injection of 0.2 mg/kg dexamethasone after induction as a prophylaxis of post-operative nausea and vomiting of Mg sulfate. Caudal block will be performed to participants before surgical incision with 1 of 2 investigators using the following technique :- The Participants are placed in left lateral position after induction of general anesthesia. The back of the participant including the sacral hiatus are carefully sterilized with an antiseptic solution and sterile drapes will be placed around the injection site. The technique will be done by introducing a 23-gauge hypodermic needle perpendicular to the sacrococcygeal membrane with the bevel in the direction of the long fibers of the membrane. The needle will be inserted until there is release of impedance as it pierced the sacrococcygeal membrane. Then, it is directed upwards so that it make an angle of 20-30° with the skin about 2 mm so that the whole bevel will be inside the sacral canal. The injection will be made over a period of about 60 s and then a small elastoplast dressing is placed over the injection site and the participant will be placed supine. Intraoperative analgesic supplement will not be given. Caudal block will be failed if HR \&/or MAP increased 10 more than the previous basal value of beginning of surgery.participants will be fasting 4-6 hours for solid foods and 2 hours for clear fluids. Balanced fluid therapy containing Na Cl, glucose, K and Ca will be infused according to body weight as follows :1st 10 kg 4 ml/kg/hour, 2nd 10 kg 2 ml/kg/hour and 1 ml//hour for every 1 kg. Then, anesthetic gas discontinued and replaced O2 100%. At the end of the operation the trachea is extubated, The participants will be transferred to the postanesthesia care unit (PACU). Intraoperative assessment:-
  • Heart rate (HR) and mean arterial blood pressure (MAP), oxygen saturation (SO2) are recorded basal before operation and every 10 mins. until the end of surgery.
  • minimal alveolar concentration (MAC) of sevoflurane is recorded every 10 mins.
  • The occurrence of intraoperative hypotension (defined as systolic arterial pressure 70 plus twice the age in years and associated with altered peripheral perfusion), requiring a fluid bolus.
  • The occurrence of intraoperative bradycardia (defined as heart rate below 60 beats min for ages above 1 years), requiring atropine.
  • Duration of anesthesia: it is the time from start of inhalation induction by sevoflurane till tracheal extubation in mins.
  • Extubation time: it is the time from termination of sevoflurane to tracheal extubation in mins.
  • Emergence time: it is the time from the end of surgery till the opening of patient's eyes in mins.
  • Interaction time: it is interval between stopping sevoflurane and verbal or physical response in mins. All are noted. Postoperative assessment in the ( PACU):-
  • The oxygen saturation (SO2), heart rate (HR), and mean arterial pressure (MAP) are monitored by the observer blinded to group allocation on admission and 10 mins till discharge (0, 10, 20, 30, 40, 50, 60mints, time of discharge) from the PACU.
  • Emergence agitations (Pediatric anesthesia emergency delirium scale (PAED):- The presence of Emergence agitation and its severity will be measured using (PAED). Item 1. The participant makes eye contact with care giver 2. The child's actions are purposeful 3. The child is aware of his/her surroundings 4. The child is restless 5. The child is inconsolable - Items 1, 2 and 3 are scored: 4 = not at all, 3 = just a little, 2 quite a bit, 1 = very much, 0 = extremely.
  • Items 4 and 5 are scored: 0 = not at all, 1 = just a little, 2 = quite a bit, 3 = very much, 4 = extremely. It will be monitored on admission and every 10 mins till discharge from the PACU (0, 10, 20, 30, 40, 50, 60 mins, time of discharge). PAED score ≥ 10 will be managed by intravenous doses of fentanyl 1micg/kg, repeated after 10 min if the child is still agitated, with a maximum total dose of 2 micg/kg. (PAED) score ≥ 10 will be considered to be a diagnostic endpoint for the development of agitation.
  • Pain score (FLACC scale) :- The presence of Pain and its severity will be measured using FLACC scale. CATEGORIES SCORING

0 1 2 Face

No particular expression or smile Occasional grimace or frown, withdrawn, disinterested. Frequent to constant quivering chin, clenched jaw. Legs

Normal position or relaxed. Uneasy, restless, tense. Kicking, or legs drawn up.

ACTIVITY

Lying quietly, normal position moves easily Squirming, shifting back and forth, tense. Arched, rigid or jerking. Cry

No cry, (awake or asleep) Moans or whimpers;occasional complaint crying steadily, screams or sobs, CONSOLABILITY

Content, relaxed. Reassured by occasional touching hugging or being talked to, distractable. Difficulty to console or comfort

It will be monitored on admission and every 10 mins till discharge from the PACU (0, 10, 20, 30, 40, 50, 60 mins, time of discharge). If the FLACC pain scale score is noted at any time to be 4 or more, the patient will be given1micg/kg fentanyl I.V and repeated after 10 mins, if the participant is still in pain with a maximum total dose 2 mg/kg

  • Time of first postoperative administration of fentanyl :- in mints
  • Modified Aldrete score :- The discharge from the PACU will be measured using Modified Aldrete score. Items are :-

Activity:

  1. able to move 4 extremities voluntarily or on command
  2. able to move 2 extremities voluntarily or on command 0. unable to move extremities voluntarily or on command

Respiration:

  1. able to breath deeply and cough freely
  2. dyspnea or limited breathing 0. apneic

Circulation:

  1. BP +/- 20% of pre-anesthetic level
  2. BP +/- 20% to 49% of pre-anesthetic level 0. BP +/- 50% of pre-anesthetic level

Consciousness:

  1. fully awake
  2. arousable on calling 0. not responding

O2 saturation :

  1. able to maintain O2 saturation <92% on room air
  2. needs O2 inhalation to maintain O2 saturation <90% 0. O2 saturation >90% even with O2 supplement. It will be monitored on admission and every 10 mins till discharge from the PACU (0, 10, 20, 30, 40, 50, 60 mins, time of discharge). Participants will be discharged from the PACU after adequate control of agitation and pain, and when they has achieved Modified Aldrete score characteristics of ≥ 9,

Postoperative complications :- All post operative complications are also recorded by the observer blinded to group allocation which include :-

  • The occurrence of Postoperative nausea and vomiting (PONV) :-
  • (PONV) is treated as needed with i.v.ondansetron 0.06 mg/kg every 4 h.
  • The occurrence of postoperative respiratory depression (defined as oxygen saturation below than 95%) and respiratory rate below than 10 breaths/min.
  • The occurrence of Postoperative Laryngospasm or Bronchospasm.
  • The occurrence of postoperative Hypotension definition and treatment as mentioned before.
  • The occurrence of postoperative Bradycardia definition and treatment as mentioned before.

Statistical analysis

Statistical analysis will be done by using statistical package for social scientists (SPSS) program version 16. Data will be proved parametric by using kolmogorov -Smi mov test. The quantitative data will be presented in the form of mean and standard Deviation. One-way ANOVA test will be used to compare between quantitative data of the three groups. Paired t-test will be used to study between two values in the same group. Pain score, sedation score will be represented by median and range and will be analyzed by Kruskal-Wallis test to compare between the three groups. Mann-Whitney test will be used for comparison between 2 groups separately. Significance will be considered when P-value is less than 0.05

Sample size The primary outcomes was the incidence of emergence agitation. A previous study on the effect of magnesium sulfate infusion on the incidence and severity of emergence agitation in children under going adenotonsillectomy under sevoflurane anesthesia reported a 72% incidence of emergence agitation. (14). We presumed that a clinically significant difference would be 50% between the incidence of agitation in the intervention and control groups. With a power of 85% (a = 0.05, two-tailed), the sample size was calculated to be 93 patients (31 in each group). The sample size was calculated using Power Analysis and Sample Size 12 software (NCSS, Kay seville, ut USA).

Being tested
Bupivacaine, Magnesium sulfate 50mg, Magnesium sulfate 30 mg
Keywords
Sevoflurane-, Emergence agitation, Magnesium sulfate, Children
Medical subject headings
Emergence Delirium, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BupivacaineDrug

    Also called local anesthetic drug

    caudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline.

  • Magnesium sulfate 50mgDrug

    Also called non anesthetic N-methyl-D-aspartate receptor antagonist

    caudal block with bupivacaine 0.25% 1mg/kg plus Magnesium sulfate 50 mg diluted in 10 cm saline.

  • Magnesium sulfate 30 mgDrug

    Also called non anesthetic N-methyl-D-aspartate receptor antagonist

    caudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline.

    + I.V injection of Magnesium sulfate 30mg/kg diluted in 10 cm saline over 10 mins then, fol I.V infusion one ampule of Magnesium sulfate 500mg diluted in 50 cm saline with rate 10 mg/kg/h.

Study groups in NCT03846284
Study groupRoleWhat they receive
Bupivacaine (B group)Placebo comparatorcaudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline. + I.V injection of 10 cm saline over 10 mins then, I.V infusion 50 cm saline with rate 10-20 ml/h according to child weight.
Receives: Drug: Bupivacaine
Magnesium sulfate caudal (MC group)Experimentalcaudal block with bupivacaine 0.25% 1mg/kg + Magnesium sulfate 50 mg diluted in 10 cm saline. + I.V injection of 10 cm saline over 10 mins then, I.V infusion of 50 cm saline with rate 10-20 ml/h according to child weight.
Receives: Drug: Bupivacaine; Drug: Magnesium sulfate 50mg
Magnesium sulfate I.V (M V group)Experimentalcaudal block with bupivacaine 0.25% 1mg/kg diluted in 10 cm saline. + I.V injection of Magnesium sulfate 30mg/kg diluted in 10 cm saline over 10 mins then, I.V infusion one ampule of Magnesium sulfate 500mg diluted in 50 cm saline with rate 10 mg/kg/h.
Receives: Drug: Bupivacaine; Drug: Magnesium sulfate 30 mg

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With sevoflurane-agitation are Assessed by Pediatric anesthesia emergency delirium scale (PAED) in 3 groups caudal versus intravenous magnesium sulfate infusions or caudal block alone

    (PAED).

    1. The child makes eye contact with care giver
    2. The child's actions are purposeful
    3. The child is aware of his/her surroundings
    4. The child is restless
    5. The child is inconsolable
    • Items 1, 2 and 3 are scored: 4 = not at all, 3 = just a little, 2 quite a bit, 1 = very much, 0 = extremely.
    • Items 4 and 5 are scored: 0 = not at all, 1 = just a little, 2 = quite a bit, 3 = very much, 4 = extremely.
    • minimal score 0 maximal score 20
    • It will be monitored on admission and every 10 mins till discharge from the PACU (0, 10, 20, 30, 40, 50, 60 mins, time of discharge).

    PAED score ≥ 10 fentanyl 1micg/kg I V will be given, repeated after 10 min if still agitated, with a maximum total dose of 2 micg/kg. (PAED) score ≥ 10 will be considered to be a diagnostic endpoint for agitation.

    Measured: up to 96 weeks

Secondary outcomes (2)
  1. Number of Participants With Pain and its severity will be measured using FLACC in 3 groups caudal versus intravenous magnesium sulfate infusions or caudal block alone after inhalational sevoflurane anesthesia in children

    FLACC scale

    0 1 2 Face No expression Occasional grimace , . Frequent quivering chin, clenched jaw.

    Legs Normal position . Uneasy,. legs drawn up. Activity Lying quietly. shifting back . Arched, rigid . Cry No cry whimpers; Crying steadily, screams, Consolability Content, . Reassured by being talked to, . Difficulty to console

    • It will be monitored on admission and every 10 mins till discharge from the (0, 10post anesthetic care unit, 20, 30, 40, 50, 60 mins, time of discharge).
    • minimal score is 0.maximal score is 12
    • If the FLACC pain scale score is noted at any time to be 4 or more, 1micg/kg fentanyl I.V and repeated after 10 mins, will be given

    -Time of first postoperative administration of fentanyl in mints -

    Measured: up to 96 weeks

  2. The discharge from the post anesthetic care unit will be measured using Modified Aldrete score after inhalational sevoflurane anesthesia in children in 3 groups

    Modified Aldrete score

    Activity:

    1. able to move 4 extremities
    2. able to move 2 extremities 0. unable to move extremities

    Respiration:

    1. able to breath deeply
    2. dyspnea 0. apneic

    Circulation:

    1. BP +/- 20% of pre-anesthetic level
    2. BP +/- 49% 0. BP +/- 50%

    Consciousness:

    1. fully awake
    2. arousable on calling 0. not responding

    O2 saturation :

    1. O2 saturation <92% on room air
    2. needs O2 O2 saturation <90% 0. O2 saturation >90%
    • It will be monitored on admission and every 10 mins till discharge from the PACU (0, 10, 20, 30, 40, 50, 60 mins, time of discharge).
    • minimal score is 0 maximal score is 10
    • Patients will be discharged from post anesthetic care unit after adequate control of agitation and pain, and when they has achieved Modified Aldrete score characteristics of ≥ 9,

    Measured: up to 96 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2019
  2. Study start8 Oct 2017
  3. Primary completion15 Nov 2018
  4. Study completion1 Aug 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Sequential
Model description
, prospective, blind,controlled clinical trial
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
93 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03846284
Sponsor's protocol ID
MS/17.05.159
Status last verified
Feb 2019
First submitted
10 Feb 2019
Last updated
19 Feb 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tomal CR, Silva AG, Yamashita AM, Andrade PV, Hirano MT, Tardelli MA, Silva HC. Assessment of induction, recovery, agitation upon awakening, and consumption with the use of two brands of sevoflurane for ambulatory anesthesia. Rev Bras Anestesiol. 2012 Mar-Apr;62(2):154-72. doi: 10.1016/S0034-7094(12)70115-0.

    PubMed 22440372
  • Dahmani S, Stany I, Brasher C, Lejeune C, Bruneau B, Wood C, Nivoche Y, Constant I, Murat I. Pharmacological prevention of sevoflurane- and desflurane-related emergence agitation in children: a meta-analysis of published studies. Br J Anaesth. 2010 Feb;104(2):216-23. doi: 10.1093/bja/aep376. Epub 2010 Jan 3.

    PubMed 20047899
  • Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology. 2004 May;100(5):1138-45. doi: 10.1097/00000542-200405000-00015.

    PubMed 15114210
  • Ahuja S, Aggarwal M, Joshi N, Chaudhry S, Madhu SV. Efficacy of Caudal Clonidine and Fentanyl on Analgesia, Neuroendocrine Stress Response and Emergence Agitation in Children Undergoing Lower Abdominal Surgeries Under General Anaesthesia with Sevoflurane. J Clin Diagn Res. 2015 Sep;9(9):UC01-5. doi: 10.7860/JCDR/2015/12993.6423. Epub 2015 Sep 1.

    PubMed 26500980
  • Patel A, Davidson M, Tran MC, Quraishi H, Schoenberg C, Sant M, Lin A, Sun X. Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing tonsillectomy and adenoidectomy. Anesth Analg. 2010 Oct;111(4):1004-10. doi: 10.1213/ANE.0b013e3181ee82fa. Epub 2010 Aug 12.

    PubMed 20705788
  • Silva LM, Braz LG, Modolo NS. Emergence agitation in pediatric anesthesia: current features. J Pediatr (Rio J). 2008 Mar-Apr;84(2):107-13. doi: 10.2223/JPED.1763.

    PubMed 18372935
  • Kim MS, Moon BE, Kim H, Lee JR. Comparison of propofol and fentanyl administered at the end of anaesthesia for prevention of emergence agitation after sevoflurane anaesthesia in children. Br J Anaesth. 2013 Feb;110(2):274-80. doi: 10.1093/bja/aes382. Epub 2012 Oct 26.

    PubMed 23103775
  • Albrecht E, Kirkham KR, Liu SS, Brull R. Peri-operative intravenous administration of magnesium sulphate and postoperative pain: a meta-analysis. Anaesthesia. 2013 Jan;68(1):79-90. doi: 10.1111/j.1365-2044.2012.07335.x. Epub 2012 Nov 1.

    PubMed 23121612
  • Abdulatif M, Ahmed A, Mukhtar A, Badawy S. The effect of magnesium sulphate infusion on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anaesthesia. Anaesthesia. 2013 Oct;68(10):1045-52. doi: 10.1111/anae.12380. Epub 2013 Aug 3.

    PubMed 23909742
  • Stewart DW, Ragg PG, Sheppard S, Chalkiadis GA. The severity and duration of postoperative pain and analgesia requirements in children after tonsillectomy, orchidopexy, or inguinal hernia repair. Paediatr Anaesth. 2012 Feb;22(2):136-43. doi: 10.1111/j.1460-9592.2011.03713.x. Epub 2011 Oct 25.

    PubMed 22023485
  • Farrag WS, Ibrahim AS, Mostafa MG, Kurkar A, Elderwy AA. Ketamine versus magnesium sulfate with caudal bupivacaine block in pediatric inguinoscrotal surgery: A prospective randomized observer-blinded study. Urol Ann. 2015 Jul-Sep;7(3):325-9. doi: 10.4103/0974-7796.152039.

    PubMed 26229319
  • Benzon HA, Shah RD, Hansen J, Hajduk J, Billings KR, De Oliveira GS Jr, Suresh S. The Effect of Systemic Magnesium on Postsurgical Pain in Children Undergoing Tonsillectomies: A Double-Blinded, Randomized, Placebo-Controlled Trial. Anesth Analg. 2015 Dec;121(6):1627-31. doi: 10.1213/ANE.0000000000001028.

    PubMed 26501831
  • Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997 May-Jun;23(3):293-7.

    PubMed 9220806
  • Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth. 1995 Feb;7(1):89-91. doi: 10.1016/0952-8180(94)00001-k. No abstract available.

    PubMed 7772368

Questions about this trial

What is this clinical trial studying?

A study testing Bupivacaine, Magnesium sulfate 50mg and Magnesium sulfate 30 mg in people with Emergence Agitation and Postoperative Pain, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With sevoflurane-agitation are Assessed by Pediatric anesthesia emergency delirium scale (PAED) in 3 groups caudal versus intravenous magnesium sulfate infusions or caudal block alone (time frame: up to 96 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03846284, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in